Combined Phycocyanin and Hematoporphyrin Monomethyl Ether for Breast Cancer Treatment via Photosensitizers Modified Fe3O4Nanoparticles Inhibiting the Proliferation and Migration of MCF-7 Cells
- 19 December 2017
- journal article
- research article
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 19 (1) , 31-41
Abstract
Photodynamic therapy (PDT), combining the laser and photosensitizers to kill tumor cells, has the potential to address many currently medical requirements. In this study, magnetic Fe3O4 nanoparticles were firstly employed as cores, and modified with oleic acid (OA) and 3-triethoxysilyl-1-Propanamine. Then, the photosensitizers phycocyanin (PC) and hematoporphyrin monomethyl ether (HMME), which might be able to stimulate the cell release of ROS after the irradiation of near infrared (NIR) laser, were grafted on the surface of such nanoparticles. Our results revealed the high-efficiency inhibition of breast cancer MCF-7 cells growing upon near-infrared irradiation both in vitro and in vivo. Furthermore, it was the synergy between the natural photosensitizers PC and the synthetic photosensitizers HMME that deeply influenced such inhibition, comparing to the groups that used either of these medicines alone. To utilize the combination of different photosensitive agents, our study thus provides a new strategy for breast cancer treatment.Keywords
Funding Information
- National Natural Science Foundation of China (31170919, 31370967, 81371646)
- Guangdong Province (2015A020212033)
This publication has 52 references indexed in Scilit:
- Recent Developments in Production and Biotechnological Applications of C-PhycocyaninBioMed Research International, 2013
- Nano-sized polymers and liposomes designed to deliver combination therapy for cancerCurrent Opinion in Biotechnology, 2013
- Nanoparticle-based combination therapy toward overcoming drug resistance in cancerBiochemical Pharmacology, 2012
- Liposomal Drug Formulations in the Treatment of Rheumatoid ArthritisMolecular Pharmaceutics, 2011
- Hematoporphyrin monomethyl ether-mediated photodynamic effects on THP-1 cell-derived macrophagesJournal of Photochemistry and Photobiology B: Biology, 2010
- Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles – opportunities & challengesNanoscale, 2010
- Delivery of the photosensitizer Pc 4 in PEG–PCL micelles for in vitro PDT studiesJournal of Pharmaceutical Sciences, 2010
- The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responsesBiomaterials, 2010
- Co‐delivery of Doxorubicin and Bcl‐2 siRNA by Mesoporous Silica Nanoparticles Enhances the Efficacy of Chemotherapy in Multidrug‐Resistant Cancer CellsSmall, 2009
- Intraperitoneal photodynamic therapy for an ovarian cancer ascite model in Fischer 344 rat using hematoporphyrin monomethyl etherCancer Science, 2007